Thebaine, also known as paramorphine, is a white, crystalline, slightly water-soluble (in pure form after a synthesis), poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum (Iranian poppy), it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine.
This report contains market size and forecasts of Thebaine in global, including the following market information:
Global Thebaine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Thebaine Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Thebaine companies in 2021 (%)
The global Thebaine market was valued at 62 million in 2021 and is projected to reach US$ 61 million by 2028, at a CAGR of -0.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Extraction from Poppy Straw Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Thebaine include Sun Pharmaceutical, Tasmanian Alkaloids, Alcaliber, TPI, Cepia-Sanofi, Taj Pharmaceuticals and Gansu Alkaloids, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thebaine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thebaine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Thebaine Market Segment Percentages, by Type, 2021 (%)
Extraction from Poppy Straw
Extraction from Opium
Global Thebaine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Thebaine Market Segment Percentages, by Application, 2021 (%)
Oxycodone
Hydrocodone
Buprenorphine
Others
Global Thebaine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Thebaine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thebaine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Thebaine revenues share in global market, 2021 (%)
Key companies Thebaine sales in global market, 2017-2022 (Estimated), (MT)
Key companies Thebaine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sun Pharmaceutical
Tasmanian Alkaloids
Alcaliber
TPI
Cepia-Sanofi
Taj Pharmaceuticals
Gansu Alkaloids